What’s at stake as Beijing beats global peers with first approval of novel therapy

China's drug regulator approved a novel, globally trialled medicine ahead of the United States, Japan, and Europe, marking a historic breakthrough as the country prioritizes biopharmaceuticals as a growth engine. The drug was filed for market approval in multiple countries, with China being the first to approve it.